Question 1

What is Inventiva?

Accepted Answer

Inventiva is a Company.

Question 2

How often does Inventiva appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 14 articles.

Question 3

When was Inventiva first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Inventiva last mentioned in news?

Accepted Answer

Last active on Jun 16, 2026.

Question 5

What is Inventiva's current news sentiment?

Accepted Answer

Aggregate sentiment score: 35 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Inventiva in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Inventiva?

Accepted Answer

Inventiva halts Euronext Paris trading (Jun 02, 2026, 7 articles).

Question 8

How did the "Inventiva halts Euronext Paris trading" event impact Inventiva?

Accepted Answer

Inventiva requested a temporary trading halt of its ordinary shares on Euronext Paris due to a proposed financing transaction. This directly affects its stock trading availability.

Question 9

How did the "Inventiva secures 
\u20ac130M debt financing" event impact Inventiva?

Accepted Answer

Inventiva secured a significant debt financing of up to \u20ac150 million, including 
\u20ac43 million from Claret Capital Partners, to fund the development of its MASH treatment, lanifibranor, through Phase 3 clinical trials and regulatory milestones. This financing strengthens its financial position and reduces dilution for shareholders.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.